Global and China Biologics and Biosimilars Sales Market Report 2020
This report studies Biologics and Biosimilars in Global and China market, focuses on top manufacturers in global and China market, involving Biologics and Biosimilars price of each type, production, revenue and market share for each manufacturer. This report also displays the production, revenue and market share of Biologics and Biosimilars in USA, EU, China, Japan, India and Southeast Asia, forecast to 2020, from 2011.
Split by product types, with production, revenue, market share and price of each type, as well as the types and price of each type price for each manufacturer in 2015 and 2016, through interviewing the key manufacturers, covering
Split by product types, with production, revenue, market share and price of each type, as well as the types and price of each type price for each manufacturer in 2015 and 2016, through interviewing the key manufacturers, covering
- Antibody
- Hormone
- Growth Factors
- Other
- Roche
- Amgen
- AbbVie
- Sanofi-Aventis
- Johnson & Johnson
- Pfizer
- Novo Nordisk
- Eli Lilly
- Novartis
- Merck
- 3sbio
- Changchun High Tech
- CP Guojian
- Biotech
- Gelgen
- Innovent
- Dong Bao
- Ganlee
- United Laboratories
- Tumor
- Diabetes
- Cardiovascular
- Hemophilia
- Other
- USA
- EU
- Japan
- China
- India
- Southeast Asia
Global and China Biologics and Biosimilars Research Report to 2020
1 BIOLOGICS AND BIOSIMILARS OVERVIEW AND PRICE OF EACH TYPE
1.1 Product Overview and Scope of Biologics and Biosimilars
1.2 Global and China Biologics and Biosimilars Production, Growth Rate 2011 to 2020
1.3 Global and China Biologics and Biosimilars Revenue, Growth Rate 2011 to 2020
1.4 Product Segments and Price of Each Type
1.4.1 Antibody and Price List (2015-2016)
1.4.2 Hormone and Price List (2015-2016)
1.4.3 Growth Factors and Price List (2015-2016)
1.4.4 Other and Price List (2015-2016)
1.5 Price List (Interviewed) of Each Type for Key Manufacturers in 2015 and 2016
1.5.1 Price List (Interviewed) of Antibody by Key Manufacturers
1.5.2 Price List (Interviewed) of Hormone by Key Manufacturers
1.5.3 Price List (Interviewed) of Growth Factors by Key Manufacturers
1.5.4 Price List (Interviewed) of Other by Key Manufacturers
1.6 Global and China Biologics and Biosimilars Market Share by Type in 2015
1.6.1 Global Biologics and Biosimilars Market Share by Type in 2015
1.6.2 China Biologics and Biosimilars Market Share by Type in 2015
2 GLOBAL AND CHINA MARKET COMPETITION ANALYSIS BY MANUFACTURERS
2.1 Global Market Biologics and Biosimilars Production, Revenue and Share List of Key Manufacturers 2015 to 2016
2.1.1 Global Market Biologics and Biosimilars Production and Share of Key Manufacturers 2015 to 2016
2.1.2 Global Market Biologics and Biosimilars Revenue and Share of Key Manufacturers 2015 to 2016
2.1.3 Global Market Biologics and Biosimilars Average Price of Key Manufacturers 2015 to 2016
2.2 China Market Biologics and Biosimilars Production, Revenue and Share of Key Manufacturers 2015 to 2016
2.2.1 China Market Biologics and Biosimilars Production and Share of Key Manufacturers 2015 to 2016
2.2.2 China Market Biologics and Biosimilars Revenue and Share of Key Manufacturers 2015 to 2016
2.3 Global Biologics and Biosimilars Manufacturing Base Distribution and Product Type of each Manufacturer
3 GLOBAL AND CHINA BIOLOGICS AND BIOSIMILARS PRODUCTION, REVENUE AND GROWTH RATE BY TYPE
3.1 Global Biologics and Biosimilars Production, Revenue and Growth Rate by Type (2011-2020)
3.1.1 Global Biologics and Biosimilars Production and Market Share by Type (2011-2020)
3.1.2 Global Biologics and Biosimilars Revenue and Market Share by Type (2011-2020)
3.1.3 Global Biologics and Biosimilars Price by Type (2011-2020)
3.2 Global Biologics and Biosimilars Production Growth Rate by Type (2011-2020)
3.2.1 Antibody Production and Production Growth Rate 2011-2020
3.2.2 Hormone Production and Production Growth Rate 2011-2020
3.2.3 Growth Factors Production and Production Growth Rate 2011-2020
3.2.4 Other Production and Production Growth Rate 2011-2020
3.3 China Biologics and Biosimilars Production, Revenue and Growth Rate by Type (2011-2020)
3.3.1 China Biologics and Biosimilars Production and Market Share by Type (2011-2020)
3.3.4 China Biologics and Biosimilars Revenue and Market Share by Type (2011-2020)
3.3.3 China Biologics and Biosimilars Price by Type (2011-2020)
3.4 China Biologics and Biosimilars Production Growth Rate by Type (2011-2020)
3.4.1 Antibody Production and Production Growth Rate 2011-2020
3.4.2 Hormone Production and Production Growth Rate 2011-2020
3.4.3 Growth Factors Production and Production Growth Rate 2011-2020
3.4.4 Other Production and Production Growth Rate 2011-2020
4 GLOBAL AND CHINA BIOLOGICS AND BIOSIMILARS KEY MANUFACTURERS ANALYSIS
4.1 Roche
4.1.1 Company Basic Information, Manufacturing Base and Competitors
4.1.2 Biologics and Biosimilars Product Segment of Roche by Type
4.1.2.1 Antibody and Price in 2015 and 2016 of Roche
4.1.2.2 Hormone and Price in 2015 and 2016 of Roche
4.1.2.3 Growth Factors and Price in 2015 and 2016 of Roche
4.1.3 Biologics and Biosimilars Production, Revenue, Price of Roche 2015 to 2016
4.1.4 Interviewee, Name and Contact
4.2 Amgen
4.2.1 Company Basic Information, Manufacturing Base and Competitors
4.2.2 Biologics and Biosimilars Product Segment of Amgen by Type
4.2.2.1 Antibody and Price in 2015 and 2016 of Amgen
4.2.2.2 Hormone and Price in 2015 and 2016 of Amgen
4.2.2.3 Growth Factors and Price in 2015 and 2016 of Amgen
4.2.3 Biologics and Biosimilars Production, Revenue, Price of Amgen 2015 to 2016
4.2.4 Interviewee, Name and Contact
4.3 AbbVie
4.3.1 Company Basic Information, Manufacturing Base and Competitors
4.3.2 Biologics and Biosimilars Product Segment of AbbVie by Type
4.3.2.1 Antibody and Price in 2015 and 2016 of AbbVie
4.3.2.2 Hormone and Price in 2015 and 2016 of AbbVie
4.3.2.3 Growth Factors and Price in 2015 and 2016 of AbbVie
4.3.3 Biologics and Biosimilars Production, Revenue, Price of AbbVie 2015 to 2016
4.3.4 Interviewee, Name and Contact
4.4 Sanofi-Aventis
4.4.1 Company Basic Information, Manufacturing Base and Competitors
4.4.2 Biologics and Biosimilars Product Segment of Sanofi-Aventis by Type
4.4.2.1 Antibody and Price in 2015 and 2016 of Sanofi-Aventis
4.4.2.2 Hormone and Price in 2015 and 2016 of Sanofi-Aventis
4.4.2.3 Growth Factors and Price in 2015 and 2016 of Sanofi-Aventis
4.4.3 Biologics and Biosimilars Production, Revenue, Price of Sanofi-Aventis 2015 to 2016
4.4.4 Interviewee, Name and Contact
4.5 Johnson & Johnson
4.5.1 Company Basic Information, Manufacturing Base and Competitors
4.5.2 Biologics and Biosimilars Product Segment of Johnson & Johnson by Type
4.5.2.1 Antibody and Price in 2015 and 2016 of Johnson & Johnson
4.5.2.2 Hormone and Price in 2015 and 2016 of Johnson & Johnson
4.5.2.3 Growth Factors and Price in 2015 and 2016 of Johnson & Johnson
4.5.3 Biologics and Biosimilars Production, Revenue, Price of Johnson & Johnson 2015 to 2016
4.5.4 Interviewee, Name and Contact
4.6 Pfizer
4.6.1 Company Basic Information, Manufacturing Base and Competitors
4.6.2 Biologics and Biosimilars Product Segment of Pfizer by Type
4.6.2.1 Antibody and Price in 2016 and 2016 of Pfizer
4.6.2.2 Hormone and Price in 2016 and 2016 of Pfizer
4.6.2.3 Growth Factors and Price in 2016 and 2016 of Pfizer
4.6.3 Biologics and Biosimilars Production, Revenue, Price of Pfizer 2016 to 2016
4.6.4 Interviewee, Name and Contact
4.7 Novo Nordisk
4.7.1 Company Basic Information, Manufacturing Base and Competitors
4.7.2 Biologics and Biosimilars Product Segment of Novo Nordisk by Type
4.7.2.1 Antibody and Price in 2017 and 2017 of Novo Nordisk
4.7.2.2 Hormone and Price in 2017 and 2017 of Novo Nordisk
4.7.2.3 Growth Factors and Price in 2017 and 2017 of Novo Nordisk
4.7.3 Biologics and Biosimilars Production, Revenue, Price of Novo Nordisk 2017 to 2017
4.7.4 Interviewee, Name and Contact
4.8 Eli Lilly
4.8.1 Company Basic Information, Manufacturing Base and Competitors
4.8.2 Biologics and Biosimilars Product Segment of Eli Lilly by Type
4.8.2.1 Antibody and Price in 2018 and 2018 of Eli Lilly
4.8.2.2 Hormone and Price in 2018 and 2018 of Eli Lilly
4.8.2.3 Growth Factors and Price in 2018 and 2018 of Eli Lilly
4.8.3 Biologics and Biosimilars Production, Revenue, Price of Eli Lilly 2018 to 2018
4.8.4 Interviewee, Name and Contact
4.9 Novartis
4.9.1 Company Basic Information, Manufacturing Base and Competitors
4.9.2 Biologics and Biosimilars Product Segment of Novartis by Type
4.9.2.1 Antibody and Price in 2019 and 2019 of Novartis
4.9.2.2 Hormone and Price in 2019 and 2019 of Novartis
4.9.2.3 Growth Factors and Price in 2019 and 2019 of Novartis
4.9.3 Biologics and Biosimilars Production, Revenue, Price of Novartis 2019 to 2019
4.9.4 Interviewee, Name and Contact
4.10 Merck
4.10.1 Company Basic Information, Manufacturing Base and Competitors
4.10.2 Biologics and Biosimilars Product Segment of Merck by Type
4.10.2.1 Antibody and Price in 2020 and 2020 of Merck
4.10.2.2 Hormone and Price in 2020 and 2020 of Merck
4.10.2.3 Growth Factors and Price in 2020 and 2020 of Merck
4.10.3 Biologics and Biosimilars Production, Revenue, Price of Merck 2020 to 2020
4.10.4 Interviewee, Name and Contact
4.11 3sbio
4.11.1 Company Basic Information, Manufacturing Base and Competitors
4.11.2 Biologics and Biosimilars Product Segment of 3sbio by Type
4.11.2.1 Antibody and Price in 2021 and 2021 of 3sbio
4.11.2.2 Hormone and Price in 2021 and 2021 of 3sbio
4.11.2.3 Growth Factors and Price in 2021 and 2021 of 3sbio
4.11.3 Biologics and Biosimilars Production, Revenue, Price of 3sbio 2021 to 2021
4.11.4 Interviewee, Name and Contact
4.12 Changchun High Tech
4.12.1 Company Basic Information, Manufacturing Base and Competitors
4.12.2 Biologics and Biosimilars Product Segment of Changchun High Tech by Type
4.12.2.1 Antibody and Price in 2022 and 2022 of Changchun High Tech
4.12.2.2 Hormone and Price in 2022 and 2022 of Changchun High Tech
4.12.2.3 Growth Factors and Price in 2022 and 2022 of Changchun High Tech
4.12.3 Biologics and Biosimilars Production, Revenue, Price of Changchun High Tech 2022 to 2022
4.12.4 Interviewee, Name and Contact
4.13 CP Guojian
4.13.1 Company Basic Information, Manufacturing Base and Competitors
4.13.2 Biologics and Biosimilars Product Segment of CP Guojian by Type
4.13.2.1 Antibody and Price in 2023 and 2023 of CP Guojian
4.13.2.2 Hormone and Price in 2023 and 2023 of CP Guojian
4.13.2.3 Growth Factors and Price in 2023 and 2023 of CP Guojian
4.13.3 Biologics and Biosimilars Production, Revenue, Price of CP Guojian 2023 to 2023
4.13.4 Interviewee, Name and Contact
4.14 Biotech
4.14.1 Company Basic Information, Manufacturing Base and Competitors
4.14.2 Biologics and Biosimilars Product Segment of Biotech by Type
4.14.2.1 Antibody and Price in 2024 and 2024 of Biotech
4.14.2.2 Hormone and Price in 2024 and 2024 of Biotech
4.14.2.3 Growth Factors and Price in 2024 and 2024 of Biotech
4.14.3 Biologics and Biosimilars Production, Revenue, Price of Biotech 2024 to 2024
4.14.4 Interviewee, Name and Contact
4.15 Gelgen
4.15.1 Company Basic Information, Manufacturing Base and Competitors
4.15.2 Biologics and Biosimilars Product Segment of Gelgen by Type
4.15.2.1 Antibody and Price in 2025 and 2025 of Gelgen
4.15.2.2 Hormone and Price in 2025 and 2025 of Gelgen
4.15.2.3 Growth Factors and Price in 2025 and 2025 of Gelgen
4.15.3 Biologics and Biosimilars Production, Revenue, Price of Gelgen 2025 to 2025
4.15.4 Interviewee, Name and Contact
4.16 Innovent
4.16.1 Company Basic Information, Manufacturing Base and Competitors
4.16.2 Biologics and Biosimilars Product Segment of Innovent by Type
4.16.2.1 Antibody and Price in 2026 and 2026 of Innovent
4.16.2.2 Hormone and Price in 2026 and 2026 of Innovent
4.16.2.3 Growth Factors and Price in 2026 and 2026 of Innovent
4.16.3 Biologics and Biosimilars Production, Revenue, Price of Innovent 2026 to 2026
4.16.4 Interviewee, Name and Contact
4.17 Dong Bao
4.17.1 Company Basic Information, Manufacturing Base and Competitors
4.17.2 Biologics and Biosimilars Product Segment of Dong Bao by Type
4.17.2.1 Antibody and Price in 2027 and 2027 of Dong Bao
4.17.2.2 Hormone and Price in 2027 and 2027 of Dong Bao
4.17.2.3 Growth Factors and Price in 2027 and 2027 of Dong Bao
4.17.3 Biologics and Biosimilars Production, Revenue, Price of Dong Bao 2027 to 2027
4.17.4 Interviewee, Name and Contact
4.18 Ganlee
4.18.1 Company Basic Information, Manufacturing Base and Competitors
4.18.2 Biologics and Biosimilars Product Segment of Ganlee by Type
4.18.2.1 Antibody and Price in 2028 and 2028 of Ganlee
4.18.2.2 Hormone and Price in 2028 and 2028 of Ganlee
4.18.2.3 Growth Factors and Price in 2028 and 2028 of Ganlee
4.18.3 Biologics and Biosimilars Production, Revenue, Price of Ganlee 2028 to 2028
4.18.4 Interviewee, Name and Contact
4.19 United Laboratories
4.19.1 Company Basic Information, Manufacturing Base and Competitors
4.19.2 Biologics and Biosimilars Product Segment of United Laboratories by Type
4.19.2.1 Antibody and Price in 2029 and 2029 of United Laboratories
4.19.2.2 Hormone and Price in 2029 and 2029 of United Laboratories
4.19.2.3 Growth Factors and Price in 2029 and 2029 of United Laboratories
4.19.3 Biologics and Biosimilars Production, Revenue, Price of United Laboratories 2029 to 2029
4.19.4 Interviewee, Name and Contact
5 GLOBAL BIOLOGICS AND BIOSIMILARS PRODUCTION BY REGIONS 2011-2020
5.1 Global Biologics and Biosimilars Production and Revenue by Regions 2011-2020
5.1.1 Global Biologics and Biosimilars Production by Regions 2011-2020
5.1.2 Global Biologics and Biosimilars Revenue by Regions 2011-2020
5.2 China Biologics and Biosimilars Production and Revenue Growth Rate 2011-2020
5.3 USA Biologics and Biosimilars Production and Revenue Growth Rate 2011-2020
5.4 EU Biologics and Biosimilars Production and Revenue Growth Rate 2011-2020
5.5 Japan Biologics and Biosimilars Production and Revenue Growth Rate 2011-2020
5.6 Southeast Asia Biologics and Biosimilars Production and Revenue Growth Rate 2011-2020
5.7 India Biologics and Biosimilars Production and Revenue Growth Rate 2011-2020
6 GLOBAL BIOLOGICS AND BIOSIMILARS CONSUMPTION BY REGIONS 2011-2020
6.1 Global Biologics and Biosimilars Consumption by Regions 2011-2020
6.2 China Biologics and Biosimilars Consumption Growth Rate 2011-2020
6.3 USA Biologics and Biosimilars Consumption Growth Rate 2011-2020
6.4 EU Biologics and Biosimilars Consumption Growth Rate 2011-2020
6.5 Japan Biologics and Biosimilars Consumption Growth Rate 2011-2020
6.6 Southeast Asia Biologics and Biosimilars Consumption Growth Rate 2011-2020
6.7 India Biologics and Biosimilars Consumption Growth Rate 2011-2020
7 GLOBAL BIOLOGICS AND BIOSIMILARS ANALYSIS BY APPLICATION AND CLIENT (BUYERS)
7.1 Global Biologics and Biosimilars Consumption and Market Share by Application 2011-2020
7.2 Tumor
7.2.1 Tumor Analysis
7.2.2 Key Client (Buyers) and Contact of Biologics and Biosimilars in Tumor
7.1 Global Biologics and Biosimilars Consumption and Market Share by Application 2011-2020
7.2 Diabetes
7.2.1 Diabetes Analysis
7.2.2 Key Client (Buyers) and Contact of Biologics and Biosimilars in Diabetes
7.1 Global Biologics and Biosimilars Consumption and Market Share by Application 2011-2020
7.2 Cardiovascular
7.2.1 Cardiovascular Analysis
7.2.2 Key Client (Buyers) and Contact of Biologics and Biosimilars in Cardiovascular
7.1 Global Biologics and Biosimilars Consumption and Market Share by Application 2011-2020
7.2 Hemophilia
7.2.1 Hemophilia Analysis
7.2.2 Key Client (Buyers) and Contact of Biologics and Biosimilars in Hemophilia
7.1 Global Biologics and Biosimilars Consumption and Market Share by Application 2011-2020
7.2 Other
7.2.1 Other Analysis
7.2.2 Key Client (Buyers) and Contact of Biologics and Biosimilars in Other
8 BIOLOGICS AND BIOSIMILARS TECHNOLOGY AND DEVELOPMENT TREND
8.1 Biologics and Biosimilars Technology Analysis
8.1.1 Global Biologics and Biosimilars Technology
8.1.2 China Biologics and Biosimilars Technology
8.2 Biologics and Biosimilars Technology Development Trend Analysis
8.2.1 Global Biologics and Biosimilars Technology Development Trend
8.2.2 China Biologics and Biosimilars Technology Development Trend
9 RESEARCH FINDINGS AND CONCLUSION
1 BIOLOGICS AND BIOSIMILARS OVERVIEW AND PRICE OF EACH TYPE
1.1 Product Overview and Scope of Biologics and Biosimilars
1.2 Global and China Biologics and Biosimilars Production, Growth Rate 2011 to 2020
1.3 Global and China Biologics and Biosimilars Revenue, Growth Rate 2011 to 2020
1.4 Product Segments and Price of Each Type
1.4.1 Antibody and Price List (2015-2016)
1.4.2 Hormone and Price List (2015-2016)
1.4.3 Growth Factors and Price List (2015-2016)
1.4.4 Other and Price List (2015-2016)
1.5 Price List (Interviewed) of Each Type for Key Manufacturers in 2015 and 2016
1.5.1 Price List (Interviewed) of Antibody by Key Manufacturers
1.5.2 Price List (Interviewed) of Hormone by Key Manufacturers
1.5.3 Price List (Interviewed) of Growth Factors by Key Manufacturers
1.5.4 Price List (Interviewed) of Other by Key Manufacturers
1.6 Global and China Biologics and Biosimilars Market Share by Type in 2015
1.6.1 Global Biologics and Biosimilars Market Share by Type in 2015
1.6.2 China Biologics and Biosimilars Market Share by Type in 2015
2 GLOBAL AND CHINA MARKET COMPETITION ANALYSIS BY MANUFACTURERS
2.1 Global Market Biologics and Biosimilars Production, Revenue and Share List of Key Manufacturers 2015 to 2016
2.1.1 Global Market Biologics and Biosimilars Production and Share of Key Manufacturers 2015 to 2016
2.1.2 Global Market Biologics and Biosimilars Revenue and Share of Key Manufacturers 2015 to 2016
2.1.3 Global Market Biologics and Biosimilars Average Price of Key Manufacturers 2015 to 2016
2.2 China Market Biologics and Biosimilars Production, Revenue and Share of Key Manufacturers 2015 to 2016
2.2.1 China Market Biologics and Biosimilars Production and Share of Key Manufacturers 2015 to 2016
2.2.2 China Market Biologics and Biosimilars Revenue and Share of Key Manufacturers 2015 to 2016
2.3 Global Biologics and Biosimilars Manufacturing Base Distribution and Product Type of each Manufacturer
3 GLOBAL AND CHINA BIOLOGICS AND BIOSIMILARS PRODUCTION, REVENUE AND GROWTH RATE BY TYPE
3.1 Global Biologics and Biosimilars Production, Revenue and Growth Rate by Type (2011-2020)
3.1.1 Global Biologics and Biosimilars Production and Market Share by Type (2011-2020)
3.1.2 Global Biologics and Biosimilars Revenue and Market Share by Type (2011-2020)
3.1.3 Global Biologics and Biosimilars Price by Type (2011-2020)
3.2 Global Biologics and Biosimilars Production Growth Rate by Type (2011-2020)
3.2.1 Antibody Production and Production Growth Rate 2011-2020
3.2.2 Hormone Production and Production Growth Rate 2011-2020
3.2.3 Growth Factors Production and Production Growth Rate 2011-2020
3.2.4 Other Production and Production Growth Rate 2011-2020
3.3 China Biologics and Biosimilars Production, Revenue and Growth Rate by Type (2011-2020)
3.3.1 China Biologics and Biosimilars Production and Market Share by Type (2011-2020)
3.3.4 China Biologics and Biosimilars Revenue and Market Share by Type (2011-2020)
3.3.3 China Biologics and Biosimilars Price by Type (2011-2020)
3.4 China Biologics and Biosimilars Production Growth Rate by Type (2011-2020)
3.4.1 Antibody Production and Production Growth Rate 2011-2020
3.4.2 Hormone Production and Production Growth Rate 2011-2020
3.4.3 Growth Factors Production and Production Growth Rate 2011-2020
3.4.4 Other Production and Production Growth Rate 2011-2020
4 GLOBAL AND CHINA BIOLOGICS AND BIOSIMILARS KEY MANUFACTURERS ANALYSIS
4.1 Roche
4.1.1 Company Basic Information, Manufacturing Base and Competitors
4.1.2 Biologics and Biosimilars Product Segment of Roche by Type
4.1.2.1 Antibody and Price in 2015 and 2016 of Roche
4.1.2.2 Hormone and Price in 2015 and 2016 of Roche
4.1.2.3 Growth Factors and Price in 2015 and 2016 of Roche
4.1.3 Biologics and Biosimilars Production, Revenue, Price of Roche 2015 to 2016
4.1.4 Interviewee, Name and Contact
4.2 Amgen
4.2.1 Company Basic Information, Manufacturing Base and Competitors
4.2.2 Biologics and Biosimilars Product Segment of Amgen by Type
4.2.2.1 Antibody and Price in 2015 and 2016 of Amgen
4.2.2.2 Hormone and Price in 2015 and 2016 of Amgen
4.2.2.3 Growth Factors and Price in 2015 and 2016 of Amgen
4.2.3 Biologics and Biosimilars Production, Revenue, Price of Amgen 2015 to 2016
4.2.4 Interviewee, Name and Contact
4.3 AbbVie
4.3.1 Company Basic Information, Manufacturing Base and Competitors
4.3.2 Biologics and Biosimilars Product Segment of AbbVie by Type
4.3.2.1 Antibody and Price in 2015 and 2016 of AbbVie
4.3.2.2 Hormone and Price in 2015 and 2016 of AbbVie
4.3.2.3 Growth Factors and Price in 2015 and 2016 of AbbVie
4.3.3 Biologics and Biosimilars Production, Revenue, Price of AbbVie 2015 to 2016
4.3.4 Interviewee, Name and Contact
4.4 Sanofi-Aventis
4.4.1 Company Basic Information, Manufacturing Base and Competitors
4.4.2 Biologics and Biosimilars Product Segment of Sanofi-Aventis by Type
4.4.2.1 Antibody and Price in 2015 and 2016 of Sanofi-Aventis
4.4.2.2 Hormone and Price in 2015 and 2016 of Sanofi-Aventis
4.4.2.3 Growth Factors and Price in 2015 and 2016 of Sanofi-Aventis
4.4.3 Biologics and Biosimilars Production, Revenue, Price of Sanofi-Aventis 2015 to 2016
4.4.4 Interviewee, Name and Contact
4.5 Johnson & Johnson
4.5.1 Company Basic Information, Manufacturing Base and Competitors
4.5.2 Biologics and Biosimilars Product Segment of Johnson & Johnson by Type
4.5.2.1 Antibody and Price in 2015 and 2016 of Johnson & Johnson
4.5.2.2 Hormone and Price in 2015 and 2016 of Johnson & Johnson
4.5.2.3 Growth Factors and Price in 2015 and 2016 of Johnson & Johnson
4.5.3 Biologics and Biosimilars Production, Revenue, Price of Johnson & Johnson 2015 to 2016
4.5.4 Interviewee, Name and Contact
4.6 Pfizer
4.6.1 Company Basic Information, Manufacturing Base and Competitors
4.6.2 Biologics and Biosimilars Product Segment of Pfizer by Type
4.6.2.1 Antibody and Price in 2016 and 2016 of Pfizer
4.6.2.2 Hormone and Price in 2016 and 2016 of Pfizer
4.6.2.3 Growth Factors and Price in 2016 and 2016 of Pfizer
4.6.3 Biologics and Biosimilars Production, Revenue, Price of Pfizer 2016 to 2016
4.6.4 Interviewee, Name and Contact
4.7 Novo Nordisk
4.7.1 Company Basic Information, Manufacturing Base and Competitors
4.7.2 Biologics and Biosimilars Product Segment of Novo Nordisk by Type
4.7.2.1 Antibody and Price in 2017 and 2017 of Novo Nordisk
4.7.2.2 Hormone and Price in 2017 and 2017 of Novo Nordisk
4.7.2.3 Growth Factors and Price in 2017 and 2017 of Novo Nordisk
4.7.3 Biologics and Biosimilars Production, Revenue, Price of Novo Nordisk 2017 to 2017
4.7.4 Interviewee, Name and Contact
4.8 Eli Lilly
4.8.1 Company Basic Information, Manufacturing Base and Competitors
4.8.2 Biologics and Biosimilars Product Segment of Eli Lilly by Type
4.8.2.1 Antibody and Price in 2018 and 2018 of Eli Lilly
4.8.2.2 Hormone and Price in 2018 and 2018 of Eli Lilly
4.8.2.3 Growth Factors and Price in 2018 and 2018 of Eli Lilly
4.8.3 Biologics and Biosimilars Production, Revenue, Price of Eli Lilly 2018 to 2018
4.8.4 Interviewee, Name and Contact
4.9 Novartis
4.9.1 Company Basic Information, Manufacturing Base and Competitors
4.9.2 Biologics and Biosimilars Product Segment of Novartis by Type
4.9.2.1 Antibody and Price in 2019 and 2019 of Novartis
4.9.2.2 Hormone and Price in 2019 and 2019 of Novartis
4.9.2.3 Growth Factors and Price in 2019 and 2019 of Novartis
4.9.3 Biologics and Biosimilars Production, Revenue, Price of Novartis 2019 to 2019
4.9.4 Interviewee, Name and Contact
4.10 Merck
4.10.1 Company Basic Information, Manufacturing Base and Competitors
4.10.2 Biologics and Biosimilars Product Segment of Merck by Type
4.10.2.1 Antibody and Price in 2020 and 2020 of Merck
4.10.2.2 Hormone and Price in 2020 and 2020 of Merck
4.10.2.3 Growth Factors and Price in 2020 and 2020 of Merck
4.10.3 Biologics and Biosimilars Production, Revenue, Price of Merck 2020 to 2020
4.10.4 Interviewee, Name and Contact
4.11 3sbio
4.11.1 Company Basic Information, Manufacturing Base and Competitors
4.11.2 Biologics and Biosimilars Product Segment of 3sbio by Type
4.11.2.1 Antibody and Price in 2021 and 2021 of 3sbio
4.11.2.2 Hormone and Price in 2021 and 2021 of 3sbio
4.11.2.3 Growth Factors and Price in 2021 and 2021 of 3sbio
4.11.3 Biologics and Biosimilars Production, Revenue, Price of 3sbio 2021 to 2021
4.11.4 Interviewee, Name and Contact
4.12 Changchun High Tech
4.12.1 Company Basic Information, Manufacturing Base and Competitors
4.12.2 Biologics and Biosimilars Product Segment of Changchun High Tech by Type
4.12.2.1 Antibody and Price in 2022 and 2022 of Changchun High Tech
4.12.2.2 Hormone and Price in 2022 and 2022 of Changchun High Tech
4.12.2.3 Growth Factors and Price in 2022 and 2022 of Changchun High Tech
4.12.3 Biologics and Biosimilars Production, Revenue, Price of Changchun High Tech 2022 to 2022
4.12.4 Interviewee, Name and Contact
4.13 CP Guojian
4.13.1 Company Basic Information, Manufacturing Base and Competitors
4.13.2 Biologics and Biosimilars Product Segment of CP Guojian by Type
4.13.2.1 Antibody and Price in 2023 and 2023 of CP Guojian
4.13.2.2 Hormone and Price in 2023 and 2023 of CP Guojian
4.13.2.3 Growth Factors and Price in 2023 and 2023 of CP Guojian
4.13.3 Biologics and Biosimilars Production, Revenue, Price of CP Guojian 2023 to 2023
4.13.4 Interviewee, Name and Contact
4.14 Biotech
4.14.1 Company Basic Information, Manufacturing Base and Competitors
4.14.2 Biologics and Biosimilars Product Segment of Biotech by Type
4.14.2.1 Antibody and Price in 2024 and 2024 of Biotech
4.14.2.2 Hormone and Price in 2024 and 2024 of Biotech
4.14.2.3 Growth Factors and Price in 2024 and 2024 of Biotech
4.14.3 Biologics and Biosimilars Production, Revenue, Price of Biotech 2024 to 2024
4.14.4 Interviewee, Name and Contact
4.15 Gelgen
4.15.1 Company Basic Information, Manufacturing Base and Competitors
4.15.2 Biologics and Biosimilars Product Segment of Gelgen by Type
4.15.2.1 Antibody and Price in 2025 and 2025 of Gelgen
4.15.2.2 Hormone and Price in 2025 and 2025 of Gelgen
4.15.2.3 Growth Factors and Price in 2025 and 2025 of Gelgen
4.15.3 Biologics and Biosimilars Production, Revenue, Price of Gelgen 2025 to 2025
4.15.4 Interviewee, Name and Contact
4.16 Innovent
4.16.1 Company Basic Information, Manufacturing Base and Competitors
4.16.2 Biologics and Biosimilars Product Segment of Innovent by Type
4.16.2.1 Antibody and Price in 2026 and 2026 of Innovent
4.16.2.2 Hormone and Price in 2026 and 2026 of Innovent
4.16.2.3 Growth Factors and Price in 2026 and 2026 of Innovent
4.16.3 Biologics and Biosimilars Production, Revenue, Price of Innovent 2026 to 2026
4.16.4 Interviewee, Name and Contact
4.17 Dong Bao
4.17.1 Company Basic Information, Manufacturing Base and Competitors
4.17.2 Biologics and Biosimilars Product Segment of Dong Bao by Type
4.17.2.1 Antibody and Price in 2027 and 2027 of Dong Bao
4.17.2.2 Hormone and Price in 2027 and 2027 of Dong Bao
4.17.2.3 Growth Factors and Price in 2027 and 2027 of Dong Bao
4.17.3 Biologics and Biosimilars Production, Revenue, Price of Dong Bao 2027 to 2027
4.17.4 Interviewee, Name and Contact
4.18 Ganlee
4.18.1 Company Basic Information, Manufacturing Base and Competitors
4.18.2 Biologics and Biosimilars Product Segment of Ganlee by Type
4.18.2.1 Antibody and Price in 2028 and 2028 of Ganlee
4.18.2.2 Hormone and Price in 2028 and 2028 of Ganlee
4.18.2.3 Growth Factors and Price in 2028 and 2028 of Ganlee
4.18.3 Biologics and Biosimilars Production, Revenue, Price of Ganlee 2028 to 2028
4.18.4 Interviewee, Name and Contact
4.19 United Laboratories
4.19.1 Company Basic Information, Manufacturing Base and Competitors
4.19.2 Biologics and Biosimilars Product Segment of United Laboratories by Type
4.19.2.1 Antibody and Price in 2029 and 2029 of United Laboratories
4.19.2.2 Hormone and Price in 2029 and 2029 of United Laboratories
4.19.2.3 Growth Factors and Price in 2029 and 2029 of United Laboratories
4.19.3 Biologics and Biosimilars Production, Revenue, Price of United Laboratories 2029 to 2029
4.19.4 Interviewee, Name and Contact
5 GLOBAL BIOLOGICS AND BIOSIMILARS PRODUCTION BY REGIONS 2011-2020
5.1 Global Biologics and Biosimilars Production and Revenue by Regions 2011-2020
5.1.1 Global Biologics and Biosimilars Production by Regions 2011-2020
5.1.2 Global Biologics and Biosimilars Revenue by Regions 2011-2020
5.2 China Biologics and Biosimilars Production and Revenue Growth Rate 2011-2020
5.3 USA Biologics and Biosimilars Production and Revenue Growth Rate 2011-2020
5.4 EU Biologics and Biosimilars Production and Revenue Growth Rate 2011-2020
5.5 Japan Biologics and Biosimilars Production and Revenue Growth Rate 2011-2020
5.6 Southeast Asia Biologics and Biosimilars Production and Revenue Growth Rate 2011-2020
5.7 India Biologics and Biosimilars Production and Revenue Growth Rate 2011-2020
6 GLOBAL BIOLOGICS AND BIOSIMILARS CONSUMPTION BY REGIONS 2011-2020
6.1 Global Biologics and Biosimilars Consumption by Regions 2011-2020
6.2 China Biologics and Biosimilars Consumption Growth Rate 2011-2020
6.3 USA Biologics and Biosimilars Consumption Growth Rate 2011-2020
6.4 EU Biologics and Biosimilars Consumption Growth Rate 2011-2020
6.5 Japan Biologics and Biosimilars Consumption Growth Rate 2011-2020
6.6 Southeast Asia Biologics and Biosimilars Consumption Growth Rate 2011-2020
6.7 India Biologics and Biosimilars Consumption Growth Rate 2011-2020
7 GLOBAL BIOLOGICS AND BIOSIMILARS ANALYSIS BY APPLICATION AND CLIENT (BUYERS)
7.1 Global Biologics and Biosimilars Consumption and Market Share by Application 2011-2020
7.2 Tumor
7.2.1 Tumor Analysis
7.2.2 Key Client (Buyers) and Contact of Biologics and Biosimilars in Tumor
7.1 Global Biologics and Biosimilars Consumption and Market Share by Application 2011-2020
7.2 Diabetes
7.2.1 Diabetes Analysis
7.2.2 Key Client (Buyers) and Contact of Biologics and Biosimilars in Diabetes
7.1 Global Biologics and Biosimilars Consumption and Market Share by Application 2011-2020
7.2 Cardiovascular
7.2.1 Cardiovascular Analysis
7.2.2 Key Client (Buyers) and Contact of Biologics and Biosimilars in Cardiovascular
7.1 Global Biologics and Biosimilars Consumption and Market Share by Application 2011-2020
7.2 Hemophilia
7.2.1 Hemophilia Analysis
7.2.2 Key Client (Buyers) and Contact of Biologics and Biosimilars in Hemophilia
7.1 Global Biologics and Biosimilars Consumption and Market Share by Application 2011-2020
7.2 Other
7.2.1 Other Analysis
7.2.2 Key Client (Buyers) and Contact of Biologics and Biosimilars in Other
8 BIOLOGICS AND BIOSIMILARS TECHNOLOGY AND DEVELOPMENT TREND
8.1 Biologics and Biosimilars Technology Analysis
8.1.1 Global Biologics and Biosimilars Technology
8.1.2 China Biologics and Biosimilars Technology
8.2 Biologics and Biosimilars Technology Development Trend Analysis
8.2.1 Global Biologics and Biosimilars Technology Development Trend
8.2.2 China Biologics and Biosimilars Technology Development Trend
9 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES AND FIGURES
Figure Picture of Biologics and Biosimilars
Figure Global Biologics and Biosimilars Production and Growth Rate 2011 to 2020
Figure China Biologics and Biosimilars Production and Growth Rate 2011 to 2020
Figure Global Biologics and Biosimilars Revenue and Growth Rate 2011 to 2020
Figure China Biologics and Biosimilars Revenue and Growth Rate 2011 to 2020
Figure Picture of Antibody
Figure Picture of Hormone
Figure Picture of Growth Factors
Figure Picture of Other
Table Price List (Interviewed) of Antibody by Key Manufacturers in 2015 and 2016
Table Price List (Interviewed) of Hormone by Key Manufacturers in 2015 and 2016
Table Price List (Interviewed) of Growth Factors by Key Manufacturers in 2015 and 2016
Table Price List (Interviewed) of Other by Key Manufacturers in 2015 and 2016
Figure Global Biologics and Biosimilars Market Share by Type in 2015
Figure China Biologics and Biosimilars Market Share by Type in 2015
Table Global Market Biologics and Biosimilars Production of Key Manufacturers 2015 to 2016
Table Global Market Biologics and Biosimilars Production Share of Key Manufacturers 2015 to 2016
Table Global Market Biologics and Biosimilars Revenue of Key Manufacturers 2015 to 2016
Table Global Market Biologics and Biosimilars Revenue Share of Key Manufacturers 2015 to 2016
Table Global Market Biologics and Biosimilars Average Price of Key Manufacturers 2015 to 2016
Table China Market Biologics and Biosimilars Production of Key Manufacturers 2015 to 2016
Table China Market Biologics and Biosimilars Production Share of Key Manufacturers 2015 to 2016
Table China Market Biologics and Biosimilars Revenue of Key Manufacturers 2015 to 2016
Table China Market Biologics and Biosimilars Revenue Share of Key Manufacturers 2015 to 2016
Table Global Biologics and Biosimilars Manufacturing Base Distribution and Product Type of each Manufacturer
Table Global Biologics and Biosimilars Production by Type (2011-2020)
Table Global Biologics and Biosimilars Production Market Share by Type (2011-2020)
Table Global Biologics and Biosimilars Revenue by Type (2011-2020)
Table Global Biologics and Biosimilars Revenue Market Share by Type (2011-2020)
Figure Global Biologics and Biosimilars Price by Type (2011-2020)
Figure Antibody Production and Production Growth Rate 2011-2020
Figure Hormone Production and Production Growth Rate 2011-2020
Figure Growth Factors Production and Production Growth Rate 2011-2020
Figure Other Production and Production Growth Rate 2011-2020
Table China Biologics and Biosimilars Production by Type (2011-2020)
Table China Biologics and Biosimilars Production Market Share by Type (2011-2020)
Table China Biologics and Biosimilars Revenue by Type (2011-2020)
Table China Biologics and Biosimilars Revenue Market Share by Type (2011-2020)
Figure China Biologics and Biosimilars Price by Type (2011-2020)
Figure Antibody Production and Production Growth Rate 2011-2020
Figure Hormone Production and Production Growth Rate 2011-2020
Figure Growth Factors Production and Production Growth Rate 2011-2020
Figure Other Production and Production Growth Rate 2011-2020
Table Roche Basic Information List
Table Antibody and Price in 2015 and 2016 of Roche
Table Hormone and Price in 2015 and 2016 of Roche
Table Growth Factors and Price in 2015 and 2016 of Roche
Table Biologics and Biosimilars Production, Revenue, Price of Roche 2015 to 2016
Table Amgen Basic Information List
Table Antibody and Price in 2015 and 2016 of Amgen
Table Hormone and Price in 2015 and 2016 of Amgen
Table Growth Factors and Price in 2015 and 2016 of Amgen
Table Biologics and Biosimilars Production, Revenue, Price of Amgen 2015 to 2016
Table AbbVie Basic Information List
Table Antibody and Price in 2015 and 2016 of AbbVie
Table Hormone and Price in 2015 and 2016 of AbbVie
Table Growth Factors and Price in 2015 and 2016 of AbbVie
Table Biologics and Biosimilars Production, Revenue, Price of AbbVie 2015 to 2016
Table Sanofi-Aventis Basic Information List
Table Antibody and Price in 2015 and 2016 of Sanofi-Aventis
Table Hormone and Price in 2015 and 2016 of Sanofi-Aventis
Table Growth Factors and Price in 2015 and 2016 of Sanofi-Aventis
Table Biologics and Biosimilars Production, Revenue, Price of Sanofi-Aventis 2015 to 2016
Table Johnson & Johnson Basic Information List
Table Antibody and Price in 2015 and 2016 of Johnson & Johnson
Table Hormone and Price in 2015 and 2016 of Johnson & Johnson
Table Growth Factors and Price in 2015 and 2016 of Johnson & Johnson
Table Biologics and Biosimilars Production, Revenue, Price of Johnson & Johnson 2015 to 2016
Table Pfizer Basic Information List
Table Antibody and Price in 2015 and 2016 of Pfizer
Table Hormone and Price in 2015 and 2016 of Pfizer
Table Growth Factors and Price in 2015 and 2016 of Pfizer
Table Biologics and Biosimilars Production, Revenue, Price of Pfizer 2015 to 2016
Table Novo Nordisk Basic Information List
Table Antibody and Price in 2015 and 2016 of Novo Nordisk
Table Hormone and Price in 2015 and 2016 of Novo Nordisk
Table Growth Factors and Price in 2015 and 2016 of Novo Nordisk
Table Biologics and Biosimilars Production, Revenue, Price of Novo Nordisk 2015 to 2016
Table Eli Lilly Basic Information List
Table Antibody and Price in 2015 and 2016 of Eli Lilly
Table Hormone and Price in 2015 and 2016 of Eli Lilly
Table Growth Factors and Price in 2015 and 2016 of Eli Lilly
Table Biologics and Biosimilars Production, Revenue, Price of Eli Lilly 2015 to 2016
Table Novartis Basic Information List
Table Antibody and Price in 2015 and 2016 of Novartis
Table Hormone and Price in 2015 and 2016 of Novartis
Table Growth Factors and Price in 2015 and 2016 of Novartis
Table Biologics and Biosimilars Production, Revenue, Price of Novartis 2015 to 2016
Table Merck Basic Information List
Table Antibody and Price in 2015 and 2016 of Merck
Table Hormone and Price in 2015 and 2016 of Merck
Table Growth Factors and Price in 2015 and 2016 of Merck
Table Biologics and Biosimilars Production, Revenue, Price of Merck 2015 to 2016
Table 3sbio Basic Information List
Table Antibody and Price in 2015 and 2016 of 3sbio
Table Hormone and Price in 2015 and 2016 of 3sbio
Table Growth Factors and Price in 2015 and 2016 of 3sbio
Table Biologics and Biosimilars Production, Revenue, Price of 3sbio 2015 to 2016
Table Global Biologics and Biosimilars Production by Regions 2011-2020
Table Global Biologics and Biosimilars Production Share by Regions 2011-2020
Table Global Biologics and Biosimilars Revenue by Regions 2011-2020
Table Global Biologics and Biosimilars Revenue Share by Regions 2011-2020
Figure China Biologics and Biosimilars Production Growth Rate 2011-2020
Figure China Biologics and Biosimilars Revenue Growth Rate 2011-2020
Figure USA Biologics and Biosimilars Production Growth Rate 2011-2020
Figure USA Biologics and Biosimilars Revenue Growth Rate 2011-2020
Figure EU Biologics and Biosimilars Production Growth Rate 2011-2020
Figure EU Biologics and Biosimilars Revenue Growth Rate 2011-2020
Figure Japan Biologics and Biosimilars Production Growth Rate 2011-2020
Figure Japan Biologics and Biosimilars Revenue Growth Rate 2011-2020
Figure Southeast Asia Biologics and Biosimilars Production Growth Rate 2011-2020
Figure Southeast Asia Biologics and Biosimilars Revenue Growth Rate 2011-2020
Figure India Biologics and Biosimilars Production Growth Rate 2011-2020
Figure India Biologics and Biosimilars Revenue Growth Rate 2011-2020
Table Global Biologics and Biosimilars Consumption by Regions 2011-2020
Table Global Biologics and Biosimilars Consumption Share by Regions 2011-2020
Figure China Biologics and Biosimilars Consumption Growth Rate 2011-2020
Figure USA Biologics and Biosimilars Consumption Growth Rate 2011-2020
Figure EU Biologics and Biosimilars Production Growth Rate 2011-2020
Figure Japan Biologics and Biosimilars Consumption Growth Rate 2011-2020
Figure Southeast Asia Biologics and Biosimilars Consumption Growth Rate 2011-2020
Figure India Biologics and Biosimilars Consumption Growth Rate 2011-2020
Table Global Biologics and Biosimilars Consumption by Application 2011-2020
Table Global Biologics and Biosimilars Consumption Market Share by Application 2011-2020
Figure Tumor Biologics and Biosimilars Consumption and Growth Rate 2011-2020
Table Key Client (Buyers) and Contact of Biologics and Biosimilars in Tumor
Figure Diabetes Biologics and Biosimilars Consumption and Growth Rate 2011-2020
Table Key Client (Buyers) and Contact of Biologics and Biosimilars in Diabetes
Figure Cardiovascular Biologics and Biosimilars Consumption and Growth Rate 2011-2020
Table Key Client (Buyers) and Contact of Biologics and Biosimilars in Cardiovascular
Figure Hemophilia Biologics and Biosimilars Consumption and Growth Rate 2011-2020
Table Key Client (Buyers) and Contact of Biologics and Biosimilars in Hemophilia
Figure Picture of Biologics and Biosimilars
Figure Global Biologics and Biosimilars Production and Growth Rate 2011 to 2020
Figure China Biologics and Biosimilars Production and Growth Rate 2011 to 2020
Figure Global Biologics and Biosimilars Revenue and Growth Rate 2011 to 2020
Figure China Biologics and Biosimilars Revenue and Growth Rate 2011 to 2020
Figure Picture of Antibody
Figure Picture of Hormone
Figure Picture of Growth Factors
Figure Picture of Other
Table Price List (Interviewed) of Antibody by Key Manufacturers in 2015 and 2016
Table Price List (Interviewed) of Hormone by Key Manufacturers in 2015 and 2016
Table Price List (Interviewed) of Growth Factors by Key Manufacturers in 2015 and 2016
Table Price List (Interviewed) of Other by Key Manufacturers in 2015 and 2016
Figure Global Biologics and Biosimilars Market Share by Type in 2015
Figure China Biologics and Biosimilars Market Share by Type in 2015
Table Global Market Biologics and Biosimilars Production of Key Manufacturers 2015 to 2016
Table Global Market Biologics and Biosimilars Production Share of Key Manufacturers 2015 to 2016
Table Global Market Biologics and Biosimilars Revenue of Key Manufacturers 2015 to 2016
Table Global Market Biologics and Biosimilars Revenue Share of Key Manufacturers 2015 to 2016
Table Global Market Biologics and Biosimilars Average Price of Key Manufacturers 2015 to 2016
Table China Market Biologics and Biosimilars Production of Key Manufacturers 2015 to 2016
Table China Market Biologics and Biosimilars Production Share of Key Manufacturers 2015 to 2016
Table China Market Biologics and Biosimilars Revenue of Key Manufacturers 2015 to 2016
Table China Market Biologics and Biosimilars Revenue Share of Key Manufacturers 2015 to 2016
Table Global Biologics and Biosimilars Manufacturing Base Distribution and Product Type of each Manufacturer
Table Global Biologics and Biosimilars Production by Type (2011-2020)
Table Global Biologics and Biosimilars Production Market Share by Type (2011-2020)
Table Global Biologics and Biosimilars Revenue by Type (2011-2020)
Table Global Biologics and Biosimilars Revenue Market Share by Type (2011-2020)
Figure Global Biologics and Biosimilars Price by Type (2011-2020)
Figure Antibody Production and Production Growth Rate 2011-2020
Figure Hormone Production and Production Growth Rate 2011-2020
Figure Growth Factors Production and Production Growth Rate 2011-2020
Figure Other Production and Production Growth Rate 2011-2020
Table China Biologics and Biosimilars Production by Type (2011-2020)
Table China Biologics and Biosimilars Production Market Share by Type (2011-2020)
Table China Biologics and Biosimilars Revenue by Type (2011-2020)
Table China Biologics and Biosimilars Revenue Market Share by Type (2011-2020)
Figure China Biologics and Biosimilars Price by Type (2011-2020)
Figure Antibody Production and Production Growth Rate 2011-2020
Figure Hormone Production and Production Growth Rate 2011-2020
Figure Growth Factors Production and Production Growth Rate 2011-2020
Figure Other Production and Production Growth Rate 2011-2020
Table Roche Basic Information List
Table Antibody and Price in 2015 and 2016 of Roche
Table Hormone and Price in 2015 and 2016 of Roche
Table Growth Factors and Price in 2015 and 2016 of Roche
Table Biologics and Biosimilars Production, Revenue, Price of Roche 2015 to 2016
Table Amgen Basic Information List
Table Antibody and Price in 2015 and 2016 of Amgen
Table Hormone and Price in 2015 and 2016 of Amgen
Table Growth Factors and Price in 2015 and 2016 of Amgen
Table Biologics and Biosimilars Production, Revenue, Price of Amgen 2015 to 2016
Table AbbVie Basic Information List
Table Antibody and Price in 2015 and 2016 of AbbVie
Table Hormone and Price in 2015 and 2016 of AbbVie
Table Growth Factors and Price in 2015 and 2016 of AbbVie
Table Biologics and Biosimilars Production, Revenue, Price of AbbVie 2015 to 2016
Table Sanofi-Aventis Basic Information List
Table Antibody and Price in 2015 and 2016 of Sanofi-Aventis
Table Hormone and Price in 2015 and 2016 of Sanofi-Aventis
Table Growth Factors and Price in 2015 and 2016 of Sanofi-Aventis
Table Biologics and Biosimilars Production, Revenue, Price of Sanofi-Aventis 2015 to 2016
Table Johnson & Johnson Basic Information List
Table Antibody and Price in 2015 and 2016 of Johnson & Johnson
Table Hormone and Price in 2015 and 2016 of Johnson & Johnson
Table Growth Factors and Price in 2015 and 2016 of Johnson & Johnson
Table Biologics and Biosimilars Production, Revenue, Price of Johnson & Johnson 2015 to 2016
Table Pfizer Basic Information List
Table Antibody and Price in 2015 and 2016 of Pfizer
Table Hormone and Price in 2015 and 2016 of Pfizer
Table Growth Factors and Price in 2015 and 2016 of Pfizer
Table Biologics and Biosimilars Production, Revenue, Price of Pfizer 2015 to 2016
Table Novo Nordisk Basic Information List
Table Antibody and Price in 2015 and 2016 of Novo Nordisk
Table Hormone and Price in 2015 and 2016 of Novo Nordisk
Table Growth Factors and Price in 2015 and 2016 of Novo Nordisk
Table Biologics and Biosimilars Production, Revenue, Price of Novo Nordisk 2015 to 2016
Table Eli Lilly Basic Information List
Table Antibody and Price in 2015 and 2016 of Eli Lilly
Table Hormone and Price in 2015 and 2016 of Eli Lilly
Table Growth Factors and Price in 2015 and 2016 of Eli Lilly
Table Biologics and Biosimilars Production, Revenue, Price of Eli Lilly 2015 to 2016
Table Novartis Basic Information List
Table Antibody and Price in 2015 and 2016 of Novartis
Table Hormone and Price in 2015 and 2016 of Novartis
Table Growth Factors and Price in 2015 and 2016 of Novartis
Table Biologics and Biosimilars Production, Revenue, Price of Novartis 2015 to 2016
Table Merck Basic Information List
Table Antibody and Price in 2015 and 2016 of Merck
Table Hormone and Price in 2015 and 2016 of Merck
Table Growth Factors and Price in 2015 and 2016 of Merck
Table Biologics and Biosimilars Production, Revenue, Price of Merck 2015 to 2016
Table 3sbio Basic Information List
Table Antibody and Price in 2015 and 2016 of 3sbio
Table Hormone and Price in 2015 and 2016 of 3sbio
Table Growth Factors and Price in 2015 and 2016 of 3sbio
Table Biologics and Biosimilars Production, Revenue, Price of 3sbio 2015 to 2016
Table Global Biologics and Biosimilars Production by Regions 2011-2020
Table Global Biologics and Biosimilars Production Share by Regions 2011-2020
Table Global Biologics and Biosimilars Revenue by Regions 2011-2020
Table Global Biologics and Biosimilars Revenue Share by Regions 2011-2020
Figure China Biologics and Biosimilars Production Growth Rate 2011-2020
Figure China Biologics and Biosimilars Revenue Growth Rate 2011-2020
Figure USA Biologics and Biosimilars Production Growth Rate 2011-2020
Figure USA Biologics and Biosimilars Revenue Growth Rate 2011-2020
Figure EU Biologics and Biosimilars Production Growth Rate 2011-2020
Figure EU Biologics and Biosimilars Revenue Growth Rate 2011-2020
Figure Japan Biologics and Biosimilars Production Growth Rate 2011-2020
Figure Japan Biologics and Biosimilars Revenue Growth Rate 2011-2020
Figure Southeast Asia Biologics and Biosimilars Production Growth Rate 2011-2020
Figure Southeast Asia Biologics and Biosimilars Revenue Growth Rate 2011-2020
Figure India Biologics and Biosimilars Production Growth Rate 2011-2020
Figure India Biologics and Biosimilars Revenue Growth Rate 2011-2020
Table Global Biologics and Biosimilars Consumption by Regions 2011-2020
Table Global Biologics and Biosimilars Consumption Share by Regions 2011-2020
Figure China Biologics and Biosimilars Consumption Growth Rate 2011-2020
Figure USA Biologics and Biosimilars Consumption Growth Rate 2011-2020
Figure EU Biologics and Biosimilars Production Growth Rate 2011-2020
Figure Japan Biologics and Biosimilars Consumption Growth Rate 2011-2020
Figure Southeast Asia Biologics and Biosimilars Consumption Growth Rate 2011-2020
Figure India Biologics and Biosimilars Consumption Growth Rate 2011-2020
Table Global Biologics and Biosimilars Consumption by Application 2011-2020
Table Global Biologics and Biosimilars Consumption Market Share by Application 2011-2020
Figure Tumor Biologics and Biosimilars Consumption and Growth Rate 2011-2020
Table Key Client (Buyers) and Contact of Biologics and Biosimilars in Tumor
Figure Diabetes Biologics and Biosimilars Consumption and Growth Rate 2011-2020
Table Key Client (Buyers) and Contact of Biologics and Biosimilars in Diabetes
Figure Cardiovascular Biologics and Biosimilars Consumption and Growth Rate 2011-2020
Table Key Client (Buyers) and Contact of Biologics and Biosimilars in Cardiovascular
Figure Hemophilia Biologics and Biosimilars Consumption and Growth Rate 2011-2020
Table Key Client (Buyers) and Contact of Biologics and Biosimilars in Hemophilia
